Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.
暂无分享,去创建一个
Sharon Bloch | Yunpeng Ye | S. Bloch | S. Achilefu | Y. Ye | Baogang Xu | Baogang Xu | Samuel Achilefu
[1] D. Taverna,et al. A Direct Test of Potential Roles for β3 and β5 Integrins in Growth and Metastasis of Murine Mammary Carcinomas , 2005 .
[2] Sanjiv S. Gambhir,et al. Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3 Expression in Living Mice , 2005 .
[3] Thorsten Persigehl,et al. Inhibition of Tumor Growth by RGD Peptide–Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature , 2005, Clinical Cancer Research.
[4] Kyung-Han Lee,et al. PMA-enhanced neutrophil [18F]FDG uptake is independent of integrin occupancy but requires PI3K activity. , 2005, Nuclear medicine and biology.
[5] O. McCarty,et al. GPVI and integrin αIIbβ3 signaling in platelets , 2005, Journal of thrombosis and haemostasis : JTH.
[6] Hung-Yun Lin,et al. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. , 2005, Endocrinology.
[7] Zhimin Shen,et al. Synthesis, in vitro, and in vivo characterization of an integrin αvβ3-targeted molecular probe for optical imaging of tumor , 2005 .
[8] A. Bosserhoff,et al. Integrin signaling in malignant melanoma , 2005, Cancer and Metastasis Reviews.
[9] E. W. Meijer,et al. A supramolecular approach to multivalent target-specific MRI contrast agents for angiogenesis. , 2005, Chemical communications.
[10] Britton Chance,et al. Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] F. Mitjans,et al. αvβ5-Integrins mediate early steps of metastasis formation , 2005 .
[12] Xiu‐da Shen,et al. Cyclic RGD Peptides With High Affinity for α5β1 Integrin Protect Genetically Fat Zucker Rat Livers From Cold Ischemia/Reperfusion Injury , 2005 .
[13] H. Ghandehari,et al. Targeting tumor angiogenic vasculature using polymer-RGD conjugates. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[14] D. Sheppard,et al. Mice Lacking the Integrin β5 Subunit Have Accelerated Osteoclast Maturation and Increased Activity in the Estrogen‐Deficient State , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] F. Mitjans,et al. Alphavbeta5-integrins mediate early steps of metastasis formation. , 2005, European journal of cancer.
[16] Zhen Cheng,et al. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. , 2005, Bioconjugate chemistry.
[17] D. Taverna,et al. Growth and Metastasis of Murine Mammary Carcinomas 5 Integrins in β 3 and β A Direct Test of Potential Roles for Updated , 2005 .
[18] Sharon Bloch,et al. Multivalent carbocyanine molecular probes: synthesis and applications. , 2005, Bioconjugate chemistry.
[19] W. Berdel,et al. Inhibition of Tumor Growth by RGD Peptide Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature. , 2004 .
[20] R. Moats,et al. In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts , 2004, Cancer Research.
[21] Mark P. Lewis,et al. αv integrins play an important role in myofibroblast differentiation , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[22] T. Tsuji. Physiological and Pathological Roles of α3β1 Integrin , 2004, The Journal of Membrane Biology.
[23] S. Achilefu. Lighting up Tumors with Receptor-Specific Optical Molecular Probes , 2004, Technology in cancer research & treatment.
[24] Samuel Achilefu,et al. Targeting the expression of integrin receptors in tumors , 2004, SPIE BiOS.
[25] Sharon Bloch,et al. Polyvalent carbocyanine molecular beacons for molecular recognitions. , 2004, Journal of the American Chemical Society.
[26] J. Reddy,et al. Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.
[27] M. Green,et al. Folate-receptor-targeted radionuclide imaging agents. , 2004, Advanced drug delivery reviews.
[28] Jean-Luc Coll,et al. Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. , 2004, Journal of the American Chemical Society.
[29] D. Beuningen,et al. Irradiation and Various Cytotoxic Drugs Enhance Tyrosine Phosphorylation and β1-Integrin Clustering in Human A549 Lung Cancer Cells in a Substratum-Dependent Manner in Vitro , 2004, Strahlentherapie und Onkologie.
[30] B. Hudson,et al. αvβ3 and αvβ5 Integrins Bind Both the Proximal RGD Site and Non-RGD Motifs within Noncollagenous (NC1) Domain of the α3 Chain of Type IV Collagen , 2004, Journal of Biological Chemistry.
[31] M. Schwaiger,et al. [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. , 2004, Bioconjugate chemistry.
[32] B. Hudson,et al. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion. , 2004, The Journal of biological chemistry.
[33] Michael S. Pepper,et al. αvβ3 and αvβ5 integrin antagonists inhibit angiogenesis in vitro , 2004, Angiogenesis.
[34] Stephen Albert Johnston,et al. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. , 2003, Cancer letters.
[35] E. Ruoslahti. The RGD story: a personal account. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[36] V. Raman,et al. Real time non‐invasive imaging of receptor–ligand interactions in vivo , 2003, Journal of cellular biochemistry.
[37] J. Frangioni. In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.
[38] R. Roy. A Decade of Glycodendrimer Chemistry , 2003 .
[39] K. Honn,et al. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. , 2003, Cancer research.
[40] Horst Kessler,et al. Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation. , 2003, Chemistry.
[41] Yunpeng Ye,et al. Synthesis and characterization of a macrocyclic near-infrared optical scaffold. , 2003, Journal of the American Chemical Society.
[42] G. Tucker. Alpha v integrin inhibitors and cancer therapy. , 2003, Current opinion in investigational drugs.
[43] F. Lubin,et al. Regulation of epithelial cell cytokine responses by the α3β1 integrin , 2003 .
[44] S. Goodman,et al. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro. , 2003, Angiogenesis.
[45] F. Lubin,et al. Regulation of epithelial cell cytokine responses by the alpha3beta1 integrin. , 2003, Immunology.
[46] E. Fleck,et al. PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. , 2002, Circulation research.
[47] Horst Kessler,et al. The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction. , 2002, Angewandte Chemie.
[48] Woo Kyung Moon,et al. A Receptor‐Targeted Near‐Infrared Fluorescence Probe for In Vivo Tumor Imaging , 2002, Chembiochem : a European journal of chemical biology.
[49] F. Carreiras,et al. Involvement of αvβ 3 integrin and disruption of endothelial fibronectin network during the adhesion of the human ovarian adenocarcinoma cell line IGROV1 on the human umbilical vein cell extracellular matrix , 2002, International journal of cancer.
[50] E. Fleck,et al. PPAR Inhibits TGF TGF TGF – Induced 5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad 4 , 2002 .
[51] I. Kirby,et al. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by αvβ1 integrin and can be modulated by changes in β1 integrin function , 2001, Journal of Gene Medicine.
[52] S. Achilefu,et al. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. , 2001, Journal of biomedical optics.
[53] J. Sacchettini,et al. Multivalent protein-carbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction. , 2001, Biochemistry.
[54] M Schwaiger,et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[55] S. Mousa,et al. Human platelet αIIbβ3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin , 2000 .
[56] S. Achilefu,et al. Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. , 2000, Investigative radiology.
[57] Y. Takada,et al. Human Parechovirus 1 Utilizes Integrins αvβ3 and αvβ1 as Receptors , 2000, Journal of Virology.
[58] R. Hynes,et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. , 2000, The Journal of clinical investigation.
[59] R. Midura,et al. Activation of Integrin αVβ3 Regulates Cell Adhesion and Migration to Bone Sialoprotein , 2000 .
[60] S. Mousa,et al. Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin. , 2000, Coronary artery disease.
[61] R. Midura,et al. Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. , 2000, Experimental cell research.
[62] R. Langlois,et al. Photodynamic Therapy: Tumor Targeting with Adenoviral Proteins , 1999, Photochemistry and photobiology.
[63] Horst Kessler,et al. N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists , 1999 .
[64] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[65] S. Teitelbaum,et al. The Integrin αvβ5 Is Expressed on Avian Osteoclast Precursors and Regulated by Retinoic Acid , 1999 .
[66] S. Teitelbaum,et al. The integrin alphavbeta5 is expressed on avian osteoclast precursors and regulated by retinoic acid. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[67] S. Goodman,et al. N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. , 1999, Journal of medicinal chemistry.
[68] F. Ross,et al. Differential Expression of αv Integrins in K1735 Melanoma Cells , 1999, Invasion and Metastasis.
[69] S. Teitelbaum,et al. Granulocyte macrophage-colony stimulating factor reciprocally regulates alphav-associated integrins on murine osteoclast precursors. , 1998, Molecular endocrinology.
[70] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[71] X. Li,et al. Differential expression of alphav integrins in K1735 melanoma cells. , 1998, Invasion & metastasis.
[72] E. Maxwell,et al. Biochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor , 1997 .
[73] M. Crow,et al. The inhibition of vascular smooth muscle cell migration by peptide and antibody antagonists of the alphavbeta3 integrin complex is reversed by activated calcium/calmodulin- dependent protein kinase II. , 1997, The Journal of clinical investigation.
[74] S. T. Pottratz,et al. Gamma‐interferon inhibits Pneumocystis carinii attachment to lung cells by decreasing expression of lung cell‐surface integrins , 1997, European journal of clinical investigation.
[75] E. Maxwell,et al. Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor. , 1997, The Journal of pharmacology and experimental therapeutics.
[76] V. Hruby,et al. Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[77] R. Swerlick,et al. Integrins: Role in Cell Adhesion and Communication , 1996, Annals of the New York Academy of Sciences.
[78] K. Burridge,et al. Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.
[79] P. Reilly,et al. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. , 1995, Journal of immunology.
[80] L. Campisi,et al. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2 , 1994, Journal of virology.
[81] D. Sheppard,et al. Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. , 1992, The Journal of biological chemistry.
[82] R. Timpl,et al. Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1 , 1991, FEBS letters.
[83] E. Ruoslahti,et al. Arg-Gly-Asp: A versatile cell recognition signal , 1986, Cell.
[84] E. Ruoslahti,et al. The cell attachment determinant in fibronectin , 1985, Journal of cellular biochemistry.
[85] Erkki Ruoslahti,et al. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.